Punched in the face

Robert P. Seawright writes on his blog that investors have to face fear every day, more so on some days than others. To quote Jason Zweig paraphrasing Mike Tyson, “investors always have a plan until the market punches them in the face.” Every investor got punched in the face during 1Q 2020. Over and over. What’s an investor to do? The obvious temptation is to sell and maybe hide, but betting against the market is a dangerous business. Peter Lynch famously said that more money has been lost trying to avoid bad markets than in the bad markets themselves.

We humans don’t handle the stress well. As Laurence Gonzales explained in Deep Survival, “it’s easy to demonstrate that many people (estimates run as high as 90 per cent), when put under stress, are unable to think clearly or solve simple problems. They get rattled. They panic. They freeze.”

Our quite natural reaction to market volatility, to fear, is to bail. Trying to time the market in that way comes with a crazy-high degree of difficulty. Market-timing successfully means making many immensely difficult and complicated decisions and being consistently right. There is no reason to expect anyone to be able consistently to navigate difficult markets without losses.

On the other hand, staying in the market has significant advantages. Studies concluded that an average of just three days per year generated 95 per cent of all the market gains. Long-term returns accrue in bunches, and, in the markets as in the lottery, you’ve got to be in it to win it (although the market offers an exponentially greater chance of success). Moreover, the majority of the market’s best days occur within two weeks of the worst days (as we’ve seen recently), meaning that if you could somehow avoid the worst days, you would almost surely miss a lot of best days. It generally pays to stay invested.

Trying to “go to cash” at opportune times and, equally importantly, buying back in at the right time, is a loser’s game. Market timing strategies are frequently triedrarelyif eversuccessfully. Stocks are worth their volatility, the necessary price you pay for the much higher expected returns of stocks as compared with other investment choices. Accordingly, the longer the time frame we use for reference, the more powerful stocks become.

That’s why truly long-term investors shouldn’t worry about market volatility, which raises what is likely the crucial question: Are you a long-term investor? Those who recognize that fear will get the better of them might consider a portfolio mechanism like a pressure relief valve to try to help manage their fears. A decent portfolio that you can stick with is far better than a perfect portfolio you can’t. [Quick Check: How often did you check your portfolio last week? If your answer is something like, “A lot,” Seawright may well be talking about you]

Seawright concludes that despite the current turmoil, the difficulties of which should not be underestimated, the probabilities still favour investment. By a lot. Our brains all echo with fearful thoughts, whispers, and imprecations. For most of us, most of the time, we’d do well to ignore them about our investment choices.

To some extend pain is addressed by RBI- Mr Dinesh Khara, SBI

Update on the Indian Equity Market:

On Wednesday Nifty closed -4.0% lower at 8,253. Among the sectoral indices NIFTY IT (-5.5%), NIFTY Bank (-4.9%), NIFTY PVT Bank (-4.9%) closed lower. None of the sectors closed on a positive note. Tech Mahindra (-9.4%), Kotak Bank (-8.7%), and AXIS Bank (-6.2%) led the losing stocks. Hero Motocorp (+2.5%), Bajaj Auto (+1.0%), Bajaj Finance (+0.5%) were among the top gainers.

Excerpts from an interview of Mr Dinesh Khara, MD- Global Banking and subsidiaries of State Bank Of India with CNBC-TV18 dated 31st March 2020:

  • Speaking on recent measures by RBI Mr Khara said the steps taken by RBI have mitigated the stress which the bank would have seen on account of the 21-days lockdown which has been announced.
  • However, the only thing could be the special mention accounts – SMA-I and SMA-II, which normally has a tendency of seeing the recovery towards the latter half of the month. So there, the bank might face some kind of a situation but that also is being resorted through follow up mechanism.
  • He added the pain has been addressed to an extent of about 90 %.
  • Speaking about the moratorium, he said everybody is entitled to the moratorium unless they opt-out.
  • For the next quarter, on the margin front, the bank has not looked at this point as the issue is evolving.
  • On asset quality, Mr Khara said the bank is in the process of evaluating the impact and it would be too early to say anything.
  • On SMEs, SBI announced an emergency package for SMEs, which is 10 per cent of the working capital for all the accounts which are performing. This package was announced even before the steps taken by RBI.
  • Speaking about loan growth he said after the lockdown is taken off, there would be pent-up demand and to meet that demand, the corporates might go for shoring up their working capital too. Apart from that, there is bound to be some kind of reconstruction effort post COVID-19 and the bank is confident that will also bring in opportunities for credit growth.

Consensus Estimate: (Source: market screener and Investing.com websites)

  • The closing price of SBI was ₹ 187/- as of 01-April-2020.  It traded at 0.7x/ 0.6x/ 0.5x the consensus Book value per share estimate of ₹ 249/277/312 for FY20E/ FY21E/ FY22E respectively.
  • The consensus average target price for SBI is ₹ 384/- which implies a PB multiple of 1.2x on FY22E BVPS of ₹312/-.

Managing fixed costs is the foremost challenge- Vinod Aggarwal, MD & CEO, VECV

Update on the Indian Equity Market:

Following its global peers, Indian markets traded higher on Tuesday with Nifty closing 3.8% higher at 8,597. It was a muted day for the corporate news flow as the country is busy controlling the spread of Coronavirus. All the sectoral indices closed the day higher with FMCG (5.8%), METAL (5.2) and PHARMA (4.1%) leading the list. Within the index, BPCL (13.6%), BRITANNIA (8.6%) and GAIL (8.1%) were the highest gainers whereas INDUSINDBK (-15.1%), EICHERMOT (-2.7%) and CIPLA (-2.2%) were the highest losers.

Edited excerpts of an interview with Mr Vinod Aggarwal, MD & CEO, Volvo Eicher Commercial Vehicles, published on CNBC TV18 on 30th March 2020:

  • The Supreme Court has provided relief to the auto manufacturers by allowing the sale of BS-IV inventory for 10 days after the lockdown ends. Earlier, the last registration date for BS-IV compliant vehicles was 31st March 2020.
  • Mr Aggarwal said that the management was not expecting any relief regarding BS-IV vehicles. The biggest concern for the manufacturers is regarding registration of vehicles which have been sold. He highlighted that because of lockdown, the customers still haven’t got the registration number for the purchased vehicles and the stock is large. This is a major challenge for the CV industry and for Volvo Eicher Commercial Vehicles (VECV).
  • He said that the sales which were earlier under negotiation or finalization have been cancelled. This along with lockdown is impacting the auto industry as well as the company.
  • He highlighted that the lockdown has created cash management problem. The challenge for the company is to manage the fixed costs in the immediate future. The company has 12,000 to 15,000 employees on its payroll as well as there are other fixed expenses like rents, minimum charges for power and other security expenses for the plant.
  • He further mentioned that the second challenge is going to be the setup time to get back to the normal operations. Whenever the lockdown is opened up, the supply chain would be impacted and how fast they are able to come back has to be seen. Most of the workmen or the people who have been working on the line have migrated back to their villages. To get them back to work is going to be a very big challenge. It means that whenever the lockdown is over, it will take some time for the life to come back to normal.

Consensus Estimate: (Source: market screener website)

  • The closing price of Eicher Motors was ₹ 12,973/- as of 31-March-2020. It traded at 17x/ 16x/ 13x the consensus EPS estimate of ₹ 762/ 815/ 974/- for FY20E/ FY21E/ FY22E respectively.
  • The consensus target price of ₹ 20,030/- implies a PE multiple of 21x on the FY22E EPS estimate of ₹ 974/-

Merged entity will help face the lockdown better- Rajkiran Rao, Union Bank

Update on the Indian Equity Market:
On Monday, NIFTY closed around 4.4% lower to end at 8,281 as coronavirus cases rose to over a thousand in India, which has raised concerns about the impact to businesses and growth. Pharma (+1.4%) and FMCG (+0.7%) were the only gainers amongst the sectoral indices. Realty (-7.8%), Financial Services (-7.4%), and Private Bank (-6.2%) led the losers. Cipla (+6.7%), Tech M (+4.7%), and Nestle India (+3.8%) were the top gaining stocks whereas Bajaj Finance (-11.9%), HDFC (-10.8%), and Kotak Bank (-8.4%) led the losers.

The merged entity will help face the lockdown better- Rajkiran Rao, Union Bank

Union Bank of India will become the fifth-largest state-run bank after Andhra Bank and Corporation Bank merge with it on April 1.

Edited excerpts of an interview with Mr. Rajkiran Rao, CEO, Union Bank published in the Economic Times on 30th March 2020:

  • Six banks are being merged with larger peers to get economies of scale. Postponing the merger after having completed the legal process would not have been a good thing. Stalling it in March, once the share swap ratios were announced was not advisable.
  • As a merged entity, the bank is better capitalized and take-off wouldn’t be an issue. A combined entity is better positioned to handle this unprecedented event because of its larger capital base, branch network and better teams to handle.
  • Changes due to the merger will happen gradually. Thus, there is no difference for the frontline staff or for the customers. The extent of damage caused by the Covid-19 breakout will be done only after it is over. Capital raising from the market will also be assessed only after the outbreak is over.
  • More than 700 branches have been identified, which can be rationalized. In cities, there are branches next to each other or in the same building. This will take three years. In the first year, more than 300 branches will be rationalized. Fresh branches will also be opened. Regional offices in new centers like Amritsar, Bhagalpur, and Mau will be opened.
  • The acquisition will make Union Bank one of the strongest banks in Southern India, with more than 30 percent market share in Andhra Pradesh and Telangana. There will be more than 2,000 branches in these two states, thus enabling them to leverage their presence in the South which complements their strengths in the North and West India.
  • Post the merger, they are looking to strengthen their gold loan business, which is something they have not done before. There will be an addition to the MSME portfolio in the South with a better underwriting process. They are looking to deepen corporate relationships because of the stronger capital base and larger size. Places to open mid-corporate branches have already been identified.
  • Mr. Rao is of the opinion that branch rationalization will not lead to job cuts. Their recruitment is on track and every year, they are recruiting new people to replace the ones retiring. The total strength post-merger will be 75,000 compared to Union Bank’s 38,000. The rationalization of administrative offices and branches will give some manpower to be redeployed in other verticals.
  • Talking about the impact of the merger on the customers, he said they have normalized the interest rates across the three banks. On the advances side, new borrowers of Andhra and Corporation Bank will get a 20bps lower rate in some slabs. RBI’s rate cut announcement on 27th March will further bring down the rates from April 1. Customers will gradually migrate to Union Bank’s centralized platform which will help in faster turnaround time.
  • To fully integrate the IT systems of Corporation Bank, which has the same Finacle 10 platform as Union Bank, but with a slightly older version, it will take six to nine months. For Andhra Bank, which is on the Finacle 7, it will take nine to twelve months. There will be no change in the account numbers after the platforms merge, and credit and debit cards will be issued by Union Bank only after they expire.

Consensus Estimate: (Source: market screener, investing.com websites)

  • The closing price of Union Bank of India was ₹ 29/- as of 30-March-2020. It traded at 0.3x / 0.3x/ 0.2x the consensus book value estimate of ₹ 110/ 115/ 127 for FY20E/ FY21E/ FY22E respectively.
  • The consensus target price of ₹ 67/- implies a PB multiple of 0.5x on the FY22E book value of ₹ 127/-.

Focus is on building capacity for home visits – Ameera Shah of Metropolis

Update on the Indian Equity Market:

On Friday, NIFTY closed marginally higher at 8,660 (+0.2%). The top losers in NIFTY50 were Bajaj Finance (-7.9%), Hero Motocorp (-7.9%) and IndusInd bank (-5.7%). Top gainers in NIFTY50 were Coal India (+6.4%), Axis Bank (+6.2%) and Cipla (+6.1%). Top sectoral losers were Auto (-2.4%), Media (-1.1%) and Realty (-0.4%) and top sectoral gainers were Bank (+1.8%), Pvt Banks (+1.7%) and Metal (+0.8%).

We offer research services on the Indian equity market and plan to offer investment advice shortly. For information on our services, please visit our website http://www.assetmultiplier.co.in/

Excerpts from an interview of Ameera Shah, MD of Metropolis and Sudarshan Jain, Secretary-General of Indian Pharmaceutical Alliance with CNBC -TV18 dated 26th March 2020:

  • A lot of people have similar symptoms to COVID-19, flu-like symptoms, sore throat, fever, and cough and are wanting to get checked. So, they are seeing a lot of demand in cities for patients with prescriptions wanting to test for coronavirus.
  • Right now they are focusing on building the capacity for home visits but the biggest challenge that they are having at this point is their manpower who are willing to go for home services to people’s houses.
  • They are having a challenge in having enough instrumentation, enough reagents and chemicals to do the testing.
  • While they could collect samples in Delhi, Chennai, or Bangalore, bringing them to Mumbai is becoming a challenge because of the lack of commercial flights.
  • The stocks are available for 3-4 months requirement. As far as hydroxychloroquine and azithromycin is concerned, they have got the capacity to produce 3-4 million tablets of hydroxychloroquine in the country. So, they are totally prepared and they have got all the capability for the production of the goods.
  • Zydus Cadila and IPCA are the world’s largest producers and they can totally prepared to supply whatever the requirement. They are ramping it up and are in discussions with all the city governments. They are totally prepared for supplying the products.

Consensus Estimate: (Source: market screener and investing.com websites)

  • The closing price of Metropolis Healthcare was ₹ 1,370/- as of 27-March-2020.  It traded at 44x/ 37x/ 31x the consensus earnings estimate of ₹ 31.4/ 36.6 /44.5 for FY20E/21E/22E respectively.
  • The consensus target price for Metropolis Healthcare is ₹ 1,577/- which implies a PE multiple of 35x on FY22E EPS of ₹ 44.5/-.

COVID-19 impact: Have requested RBI that moratorium sought by consumers should be given, says M&M Fin Services

Update on the Indian Equity Market:

On Thursday, NIFTY continued gains for the 3rd day and ended at 8,641 (+3.9%). Among the sectoral indices, Pvt Bank gained the most while no sector index ended negatively. Pvt bank (+8.3%), Realty (+7.3%) and BANK (+6.4%) were the top gainers. Out of the NIFTY50 stocks, IndusInd bank (+46.0%), L&T (+10.0%) and Bajaj Finance (+9.3%) rallied the most, while GAIL (-3.3%), HCL Tech (-2.6%) and Sun Pharma (-2.5%) were the worst performers for the day.

Edited excerpts of an interview with Mr Ramesh Iyer, Vice Chairman & Managing Director of Mahindra & Mahindra Financial Services Ltd; dated 25th March 2020. The interview aired on CNBC-TV18.

  • Original equipment manufacturers (OEMs) have shut down production due to COVID-19, which obviously have an impact on vehicle financiers.
  • For OEMs at the beginning of 4Q FY20, the volumes started to shrink because everybody was preparing for BS-VI transition and therefore the inventory levels started to come down. Now with the COVID-19 scare – even the little possible sales that were likely to happen have come to an end, according to him.
  • He added the month of January-February was average; March has been absolute no-number kind of a month, so he thinks that it would be a low single-digit growth in loan book or for some it may not even be that.
  • The Company has told the RBI about consumers asking them for a moratorium and has requested RBI to provide the same.
  • They have also told RBI that these are the times where maybe the non-performing assets (NPAs) norms itself will have to be rewritten to say it is not 90-days delinquent but 180-days kind of a delinquent and it is more to protect the good customers who have been paying so far.
  • There is uncertainty about tomorrow. So people had started becoming cautious but even more important is that the overall activities have started to reduce and therefore people’s earnings will start to reduce but these are times where instead of worrying about what is going to happen to the growth and things like that – the Company will be looking at ‘how do they help out the consumers’.
  • The current situation is still not as impactful in the rural market as seen in urban according to him. People will have to figure out after things get normal. They will start relooking at what else to do, how else to do. So the real impact will be known only three months down the line.
  • If consumers need some kind of temporary short-term loan after things get to some normal then the Company will look at what could be that short-term small-ticket loans to the existing consumers whom they may want to support and partner them to come out of this situation as things start to improve.

Consensus Estimate: (Source: market screener, investing.com websites)

  • The closing price of M&M Financial Services Ltd was Rs 169/- as of 26-March-2020. It traded at 0.9x / 0.8x/ 0.7x the consensus book value estimate of Rs 190/ 211/ 238 for FY20E/ FY21E/ FY22E respectively.
  • The consensus target price of Rs 394/- implies a PB multiple of 1.7x on the FY22E book value of Rs 238/-

Business cannot take priority over the safety of people- Mr Pawan Goenka, MD, Mahindra & Mahindra

Update on the Indian Equity Market:

On Tuesday night, PM Narendra Modi announced a nationwide lockdown for the next 21 days to fight against the spread of Covid-19. On Wednesday, NIFTY continued gains for the 2nd day and ended at 8,318 (+6.6%). This rally might be in the expectation that an economic package to counter economic disruptions might be announced soon.

Among the sectoral indices, Financials gained the most while no sector index ended negatively. FIN SERV (+9.7%), PVT BANK (+8.5%) and BANK (+8.4%), AUTO (+4.3%) were the top gainers. Out of the NIFTY50 stocks, RELIANCE (+13.8%), HDFCBANK (+12.4%) and KOTAKBANK (+11.9%) rallied the most. INDUSINDBK (-3.3%), IOC (-3.1%) and COALINDIA (-2.8%)  were among the few stocks that ended in red.

Business cannot take priority over the safety of people- Mr Pawan Goenka, MD, Mahindra & Mahindra

Edited excerpts of an interview with Mr Pawan Goenka, Managing Director of Mahindra & Mahindra; dated 23rd March 2020. The interview aired on CNBC-TV18.

  • As a contribution to tackling the Covid-19 crisis, the Mahindra Group has taken certain steps. The Group has started work on how their manufacturing facilities can be used to make ventilators. They have put their projects team on standby to assist the government or the army in erecting temporary care facilities. In addition, Mahindra Holidays will offer their resorts as temporary care facilities.
  • The foremost consideration is given to the well-being of the group’s employees. Plants in Nagpur, Kandivali and Chakan have already shut down. Over the next few days, most plants will be shut down.
  • No one is in a mood to buy cars right now. Dealerships are also shutting down due to lockdowns. The automotive business is slowing down. Tractor business is also slowing down, although not to the same extent.
  • Mahindra Group is playing it by the day as things are very dynamic. It is difficult to predict how long the shutdown will last. If lockdown lasts only until 31st March, the business that has slowed down will come back in the next 2-3 months. If lockdown lasts longer than 31st March, the comeback will take much longer.
  • Need for tractors in agriculture cannot disappear. The tractor buying peaks in May-June period. If Mahindra does not miss out this season, then the tractor business will be fine. However, to tap that season, production will have to take place in April. But in the current scenario, the business will not take priority over the safety of the Group’s people and communities.
  • For the auto and tractor business point of view, the foremost responsibility of the company is to make payments to its suppliers and low wage earners-especially the contract workers and daily wage workers.
  • Mahindra Finance is closely watching the concern of liquidity in the market. There is a concern of EMI payments not happening but that will not happen immediately. The farmers have probably already received revenue from the previous cycle and so there might not be an issue.
  • The big unknown from the perspective of Mahindra Financial is what will happen to the financial cycle, i.e money coming into the NBFC from both borrowings and EMI payments. It is very important to get that cycle going. But right now, the sales pull will also be less hence the demand for financing will be less.
  • The group has an advantage in terms of business diversification.
  • Mr Goenka is of the opinion that although the Government is also under pressure and we should not expect too much, the government has to step in at this point. Mr Goenka has mentioned three things that he expects from the government at this point:
  1. For the auto industry, the immediate issue is the 31st March deadline to liquidate BS-IV inventory. It is not in the hands of the Government as it’s a supreme court matter. Mr Goenka is hoping that the court extends the deadline and gives extra time to liquidate the BS-IV vehicles. As no OEM is manufacturing BS-IV vehicles any longer, there is no problem of excessive dumping of those vehicles.
  2. The second area where Government intervention is needed is to help in the liquidity situation. If a moratorium of say 3 months is imposed on recognition of EMI non-payment as NPAs, NBFCs will be able to have a bit of a breathing room. The government needs to ensure that the financial cycle does not break down because it will take a long time to repair if broken.
  3. Thirdly, the Government must not delay any payments due to the industry as right now the industry needs funds.

Consensus Estimate: (Source: market screener, investing.com websites)

  • The closing price of M&M was ₹ 274/- as of 25-March-2020. It traded at 7.2x/ 7.7x/ 6.7x the consensus EPS estimate of ₹ 38.3/ 35.4/ 40.6 for FY20E/ FY21E/ FY22E respectively.
  • The consensus target price of ₹ 651/- implies a PE multiple of 16.0x on FY22E EPS of ₹ 40.6/-

Bottom of pyramid businesses & SMEs are not highly leveraged, says Aditya Puri, HDFC Bank

Update on the Indian Equity Market:

On Tuesday, NIFTY ended up 190 pts up (+2.5%) at above 7,800 level amid Finance Minister Nirmala Sitharaman announcements to move tax deadlines and ease of rules to fight Coronavirus.

Among the sectoral indices, IT (6.1%), FMCG (3.2%) and PHARMA (2. 8%) were among the top gainers while REALTY (-2.0%) was the only sector to close lower. INFY (+14.0%), ADANIPORTS (+13.8%) and BRITANNIA (+11.8%) were the top gainers. M&M (-8.0%), GRASIM (-7.7%) and IndusInd Bank (-6.8%) were the top losers.

Bottom of pyramid businesses & SMEs are not highly leveraged, says Aditya Puri, HDFC Bank

Edited excerpts of an interview with Mr Aditya Puri, Managing Director & Chief Executive Officer of HDFC Bank; dated 23rd March 2020:

  • His views on COVID-19 – He is happy with the lockdown and suggested that we should control this situation and work towards decreasing the number of cases, this will be the best thing that can happen to everyone now.
  • When asked about where he sees the financial market and economy going ahead, he commented that in such crisis financial backing is needed looking at the difficulty we will be going through. A non-schedule rate cut is necessary for both to keep the yields in check as well as to give a clear message to the market that we are willing to go to whatever stake necessary. A forbearance for the cash flow problem that the virus will create is needed as it is not that the companies are going bad, there could be cash flow mismatches and the more liquidity provided will make sure that life after the virus is better.
  • While giving a picture about his bank he said that if the companies survive, the country will survive and the banks will also survive. HDFC Bank has been working on this. They are sitting on the liquidity of USD 5 bn and their total portfolio is rated AAA at an internal risk rating of 4.3. HDFC Bank has lent most of their wholesale to 80% to AAA companies. On the PL side, they have lent to the same fellows for salary and he expects salary cuts. 75-80% of personal loans and credit cards are to the same salaried employees there. It is difficult for the Bank to take a call before laying off starts but he expects salary cuts for sure before that.
  • He stated that as far as SME portfolio is concerned compared to the others, 80% of the portfolio has got additional collateral and they have a self-funding ratio in SME of 85%. He also said that he is more concerned with the health aspect than being concerned about the bank.
  • He further added that their bottom of the pyramid on the businesses is not highly leveraged, so when they went to the ground for the shopkeepers, they are not highly leveraged. A large part of SMEs also is not highly leveraged.
  • Talking about rural India he said that it is functioning in its own world. The only thing we have to do is stop people going back there and spreading. People there have the money and the demand is coming from rural areas.
  • With regards to earnings, he said that there will not be a flat quarter or a drop in profit and investors would be surprised with the numbers. He will also create a corona reserve and come out still okay.
  • On the work from the home structure, he said that ~33% of their people are working from home now and he sees no reason why they shouldn’t continue after corona which gives a further drop in our costs. So, their cost to revenue ratio is going down. HDFC Bank has substantially increased their distribution, they have the technology and USD 5 bn of liquidity and it is still coming in.

Consensus Estimate: (Source: market screener, investing.com websites)

  • The closing price HDFC Bank was ₹ 774/- as of 23rd March 2020. It traded at 2.5x/ 2.1x/ 1.8x the consensus book value estimate of ₹ 311/ 360/ 420 for FY20E/ FY21E/ FY22E respectively.
  • Consensus target price of ₹ 1445/- implies a PBV multiple of 3.4x on FY22E EPS of ₹ 420/-

Hydroxychloroquine drug useful in clinical trials for Covid-19 infection: Cadila Chairman

Update on the Indian Equity Market:

After hitting the lower circuit in the first half of the day Nifty closed 13% lower at 7,610. Among the sectoral indices, NIFTY PVT Bank (-17.4%), NIFTY Bank (-16.2%), NIFTY Fin Services (-15.5%) closed lower. None of the sectors closed on a positive note. AXIS Bank (-27.6%), Bajaj Finserv (-27.5%), IndusInd Bank (-23.9%) closed lower. None of the NIFTY stocks closed on a positive note.

Excerpts from an interview of Mr Pankaj Patel, Chairman, Zydus Cadila with CNBC-TV18:

  • Anti-malaria drug Hydroxychloroquine has found to be useful in clinical trials of some patients with Covid-19 infection and Cadila is in a position to increase the production.
  • On Janta curfew, Mr Patel said that it is a unique idea and it will prepare everyone for a lockdown situation if any.
  • He said it is a positive step and with respect to clinical research being done, there are more than 10 drugs being tried out as a treatment for coronavirus infection.
  • A recent report by France researchers showed that hydroxychloroquine has found to be effective. So there is a possibility of use of it in the treatment of infection.
  • The company is closely watching this situation and is in a position to produce more as and when needed.
  • The manufacturing is dependent on local raw materials and there is no dependence on imported inputs so the company can supply this drug in sufficient quantity.
  • Speaking about Covid-19 impact on the company, Mr Patel said, the company does not see a challenge as the US supply will continue unless restrictions are imposed by the government. So there should not be any problem supplying drugs to the US and other markets.
  • As far as approvals are concerned, the process in on, not that for every drug approval there is an inspection necessary.
  • He added there will be some slowdown in the approval process as there is a slowdown and in the US people are working from home. However, it is not a major challenge.

Consensus Estimate: (Source: market screener website)

  • The closing price of Cadila was ₹ 281/- as of 23-March-2020.  It traded at 21.6x/ 17.5x/ 15.7x the consensus EPS estimate of ₹ 13/16/17.8 for FY20E/ FY21E/ FY22E respectively.
  • The consensus average target price for Cadila is ₹ 300/- which implies a PE multiple of 16.8x on FY22E EPS of ₹ 15.7/-.

 

Maruti Suzuki readies strategy to deal with coronavirus impact: CV Raman, Maruti Suzuki

Update on the Indian Equity Market:

Markets bounced back strongly to end a highly volatile week and Nifty closed 5.6% higher at 8,284. During the current week, Nifty traded in the range of 7,833 – 9,602, that’s a lot to digest for the investors! Out of fifty stocks from the index, 8 stocks traded above 10% and 31 stocks traded above 5%. ONGC (17.9%), GAIL (15.4%) and INFRATEL (14.9%) were the highest gainers. Five stocks among the index closed lower with INDUSINDBK (-1.4%), HDFCBANK (-1.3%) and ADANIPORTS (-1.1%) were the biggest losers. All the sectoral indices, FMCG (8.8%), IT (8.5%) and METAL (7.7%) led the gains. None of the sectors ended the day in the red.

Excerpts from an interview with Mr CV Raman, Executive Director, Maruti Suzuki published in CNBC TV-18 on 17th March 2020:

  • As Coronavirus is spreading fast across the world, Maruti Suzuki is working on two-pronged strategy to minimize the impact of the pandemic.
  • He said that officials at the company are assessing the impact of the pandemic on sales. The company has started focusing more on digital marketing and delivery of cars from service centres directly to customers. He mentioned that automakers have already reported a 15 per cent de-growth in FY20.
  • About the measures taken to curb the virus, he said that the company has issued advisories to its employees and suppliers. He added that the company is reducing physical contact by doing meetings through video conferencing and reducing visits of suppliers to Maruti’s offices.
  • While several automobile manufacturers have expressed concern about the impact of the disease on supply chains from China and South Korea, Raman said Maruti was in a position to manage supply chains well. He said that most of the tier-1 suppliers are in India and the company is able to get the supplies as per production requirements.
  • The Federation of Automobile Dealers have moved the court seeking a grace period for sell and registration of BS-IV vehicles after March 31 as dealers are saddled with inventory and coronavirus has impacted sales. Individual companies are also considering moving court to seek an extension. He said that for Maruti which began executing its BS-VI transition a year back does not need any intervention at this stage.
  • Introduction of BS-VI standards are set to make diesel vehicles significantly more expensive. Considering the cost implications, the company has stopped production of diesel cars for the moment but hasn’t ruled out a higher capacity diesel engine in future. The company currently has CNG variants in seven models and planning to increase the range of CNG offerings this year.
  • He refused to comment on future products but said that Maruti would be actively participating in the growing SUV segment.

Consensus Estimate: (Source: market screener website and investing.com websites)

  • The closing price of Maruti Suzuki was ₹ 5,094/- as of 17-March-2020.  It traded at 25x/ 20x/ 16x the consensus EPS estimate of ₹ 202/ 255/ 314 for FY20E/ FY21E/ FY22E respectively.
  • Consensus average target price for Maruti Suzuki is ₹ 7,246/- which implies a PE multiple of 23x on FY22E EPS of ₹ 314/- .